BNIP3 and osteosarcoma: In osteosarcoma, pathways such as FOXO3a/HSP90/ULK1-FUNDC1 and the FoxG1/BNIP3 axis enhance mitophagy, protecting tumor cells from cisplatin-induced apoptosis and contributing to chemoresistance (9–11).